Faculty

• 

• Fabrice André, MD

  Chair of the ESMO Translational Research and Precision Medicine Working Group
  Member of the ESMO Educational Committee and of the ESMO Breast Cancer Faculty
  Villejuif, France

  Disclosures

  Research funding from: AstraZeneca; Daiichi Sankyo; Eli Lilly and Company; Novartis; Pfizer; Roche

• 

• Martine Piccart, MD

  Professor of Oncology at the Université Libre de Bruxelles (ULB)
  Director of Medicine at the Jules Bordet Institute
  Brussels, Belgium

  Disclosures

  Consultant or advisor for: AstraZeneca; Camel-IDS; Eli Lilly and Company; Frame Therapeutics; Genentech; Gilead; Immunomedics; Immutep; Menarini; Merck Sharp & Dohme; NBE Therapeutics; Novartis; Odonate; Oncolytics; Pfizer; Precirix; Roche; Seagen Inc., formerly Seattle Genetics, Inc.
  Research funding from: AstraZeneca; Eli Lilly and Company; Genentech; Immunomedics; Menarini; Merck Sharp & Dohme; Novartis; Pfizer; Radius; Roche; Servier; Synthon

Editor

• Walid Amara, MD

  Medical Education Director, WebMD Global, LLC

  Disclosures

  Disclosure: Walid Amara, MD, has no relevant financial relationships.

Compliance Reviewer

• Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

  Associate Director, Accreditation and Compliance

  Disclosures

  Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.